Figure 3.
Figure 3. The BH1 domain mediates the interaction between anti-Bcl-2-scFv-TAT and Bcl-2. (A) Binding of anti-Bcl-2-scFv-TAT to intracellular Bcl-2. Bcl-2 was immunoprecipitated from RBL cells with anti-Bcl-2 immobilized on protein A-agarose. The binding of anti-Bcl-2-scFv-TAT (lane 1) or nonspecific scFv-TAT (lane 2) to intracellular Bcl-2 was determined by Western blot analysis using antibody against the myc tag on the scFv. (B) The sequence of the Bcl-2-BH domains and their homology to other BH domains in the Bcl-2-family proteins. The box encloses the BH domains, and the Bcl-2 sequences before and after the box complete the fragments for PCR. (C) Bcl-2 fragments BH1, BH2, BH3, and BH4 were labeled with [35S]-methionine in vitro and added to anti-Bcl-2-scFv-TAT immobilized on agarose beads. Retained [35S]-labeled fragments were determined by SDS-PAGE and autoradiography. One representative experiment of 3 is shown.

The BH1 domain mediates the interaction between anti-Bcl-2-scFv-TAT and Bcl-2. (A) Binding of anti-Bcl-2-scFv-TAT to intracellular Bcl-2. Bcl-2 was immunoprecipitated from RBL cells with anti-Bcl-2 immobilized on protein A-agarose. The binding of anti-Bcl-2-scFv-TAT (lane 1) or nonspecific scFv-TAT (lane 2) to intracellular Bcl-2 was determined by Western blot analysis using antibody against the myc tag on the scFv. (B) The sequence of the Bcl-2-BH domains and their homology to other BH domains in the Bcl-2-family proteins. The box encloses the BH domains, and the Bcl-2 sequences before and after the box complete the fragments for PCR. (C) Bcl-2 fragments BH1, BH2, BH3, and BH4 were labeled with [35S]-methionine in vitro and added to anti-Bcl-2-scFv-TAT immobilized on agarose beads. Retained [35S]-labeled fragments were determined by SDS-PAGE and autoradiography. One representative experiment of 3 is shown.

Close Modal

or Create an Account

Close Modal
Close Modal